Recent Press Releases

NanoString Announces Unexpected Death of Chief Medical Officer, J. Wayne Cowens, MD

NanoString Announces Unexpected Death of Chief Medical Officer, J. Wayne Cowens, MD SEATTLE, Aug. 27, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., (Nasdaq:NSTG) a provider of life science...

Report: Companion Testing Market Exceeded One Billion Dollars in 2013

Report: Companion Testing Market Exceeded One Billion Dollars in 2013 The market for test and pharmaceutical pairs, known as companion diagnostics in the testing industry, has grown significantly....

Corgenix Enters into Agreement to Be Acquired by Orgentec Diagnostika

Corgenix Enters into Agreement to Be Acquired by Orgentec Diagnostika Corgenix shareholders to receive $0.27 in cash Transaction valued at approximately $16 million Following the...

Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study

Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study Testing for the protein 14-3-3eta may improve the diagnosis of...

Cancer Genetics, Inc. and Leading Pathologist From Keck Medicine of USC Collaborate to Evaluate and Optimize Genomic Panel for Lymphoma

Cancer Genetics, Inc. and Leading Pathologist From Keck Medicine of USC Collaborate to Evaluate and Optimize Genomic Panel for Lymphoma Collaboration will identify and evaluate new genomic...

Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard

Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard Stool-based DNA (sDNA) screening test for colorectal cancer to be available by prescription to patients MADISON,...

Nipro Diagnostics, Inc. Announces FDA Clearance of its Newest Blood Glucose Monitoring Systems, TRUE METRIX and TRUE METRIX PRO, and Expansion of Manufacturing in the USA

Nipro Diagnostics, Inc. Announces FDA Clearance of its Newest Blood Glucose Monitoring Systems, TRUE METRIX and TRUE METRIX PRO, and Expansion of Manufacturing in the USA FORT LAUDERDALE,...

Sarepta Enters into Partnership with Flagship Biosciences to Digitally Automate the Measurement of Dystrophin, a Key Therapeutic Efficacy Marker for Muscular Dystrophy

Sarepta Enters into Partnership with Flagship Biosciences to Digitally Automate the Measurement of Dystrophin, a Key Therapeutic Efficacy Marker for Muscular Dystrophy New technology designed to...

Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology

Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology SAN DIEGO--(BUSINESS WIRE)--Aug. 21, 2014-- Illumina, Inc. (NASDAQ:ILMN)...

LabCorp Announces the Availability of InformaSeqSM Non-Invasive Prenatal Test August 19, 2014 08:45 AM Eastern Daylight Time

LabCorp Announces the Availability of InformaSeqSM Non-Invasive Prenatal Test August 19, 2014 08:45 AM Eastern Daylight Time BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America®...

MDxHealth ConfirmMDx Biomarker Associated with the Risk of Recurrence for Early Stage Prostate Cancer Patients

MDxHealth ConfirmMDx Biomarker Associated with the Risk of Recurrence for Early Stage Prostate Cancer Patients Validation Study Data Published in The Journal of Urology® IRVINE, California, and...

Cancer Genetics Reports Second Quarter 2014 Financial Results

Cancer Genetics Reports Second Quarter 2014 Financial Results Conference Call Today at 8:30 a.m. Eastern / 5:30 a.m. Pacific 0 0 0 0 August 14, 2014 07:05 ET | Source:...

Researchers identify tests to diagnose invasive aspergillosis with 100 percent accuracy

Researchers identify tests to diagnose invasive aspergillosis with 100 percent accuracy Early, more accurate detection of this potentially deadly fungus can improve patient outcomes, according to new...

Biocept Provides Second Quarter Operational Update

Biocept Provides Second Quarter Operational Update SAN DIEGO, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor...

Protagen AG Launches Landmark First Research Test Kit for Systemic Scleros

Dortmund, Germany – 13th August, 2014. Protagen AG, a company dedicated to the development of powerful diagnostic tools to address some of the most severe autoimmune diseases, has today...

Castle Biosciences Announces $11.8 Million Financing Led by New Investor HealthQuest Capital

Castle Biosciences Announces $11.8 Million Financing Led by New Investor HealthQuest Capital Funds to Expand Clinical Availability of Cutaneous Melanoma Gene Expression Profile Test Friendswood, TX...

Seventh Sense Biosystems Closes $16 Million Series B Financing

Seventh Sense Biosystems Closes $16 Million Series B Financing New Investors Siemens, Novartis and LabCorp® Join Polaris Partners and Flagship Ventures to Fund Development and Launch of Patented...

FDA approves first non-invasive DNA screening test for colorectal cancer

FDA approves first non-invasive DNA screening test for colorectal cancer Collaboration with CMS contributed to proposed Medicare coverage The U.S. Food and Drug Administration today approved...

FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Tes

FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test First time in history a technology receives FDA approval and proposed national...

Epigenomics AG Announces H1 2014 and Q2 2014 Financial Results and Reports on Operational Highlights

Epigenomics AG Announces H1 2014 and Q2 2014 Financial Results and Reports on Operational Highlights Berlin (Germany) and Germantown, MD (U.S.A.), August 12, 2014 - Epigenomics AG (Frankfurt Prime...